APIs & Intermediates

Disclaimer: Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.

No. API Therapeutic Area Status
1 Amisulpride Schizophrenia Under development
1 Brivaracetam Epilepsy Under development
1 Carbidopa Parkinson Under development
1 Edoxaban Anti-thromboti Under development
1 Elagolix Endometriosis Under development
1 Favipiravir Antivirus Under development
1 Gabapentin Epilepsy Under development
1 Oseltamivir Antivirus Under development
1 Sugammadex sodium Reversal of Neuromuscular Blockade Under development
1 Alogliptin Diabetes Validated
1 Ambrisentan Anti-hypertensive Validated
1 Apixaban Anti-thrombotic Validated
1 Aripiprazole Anti-psychotic Validated
1 Benazepril HCl Anti-hypertensive Validated
1 Canagliflozin Anti-diabetic Validated
1 Candesartan Cilexetil Anti-hypertensive Validated
1 Captopril Anti-hypertensive Validated
1 Carvedilol Anti-hypertensive Validated
1 Citalopram Hydrobromide Anti-depressant Validated
1 Dabigatran etexilate Anti-thrombotic Validated
1 Dapagliflozin Diabetes Validated
1 Dimethyl Fumarate Multiple sclerosis Validated
1 Donepezil HCl Alzheimer's disease Validated
1 Duloxetine hydrochloride Anti-depressant Validated
1 Empagliflozin Diabetes Validated
1 Enalapril Maleate Anti-hypertensive Validated
1 Eprosartan mesylate Anti-hypertensive Validated
1 Escitalopram Oxalate Anti-depressant Validated
1 Febuxostat Chronic Gout drug Validated
1 Fosinopril sodium Anti-hypertensive Validated
1 Irbesartan Anti-hypertensive Validated
1 Ketotifen hydrogen fumarate Anti-histaminic Validated
1 Lamotrigine Anti-epileptic Validated
1 Levetiracetam Anti-epileptic Validated
1 Levodopa Anti-parkinsonian Validated
1 Linagliptin Diabetes Validated
1 Lisinopril Anti-hypertensive Validated
1 Losartan potassium Anti-hypertensive Validated
1 Lurasidone Schizophrenia/Bipolar disorder Validated
1 Mirabegron Overactive bladder Validated
1 Nebivolol Anti-hypertensive Validated
1 Nevirapine Anti-AIDS Validated
1 Olmesartan medoxomil Anti-hypertensive Validated
1 Paroxetine HCl, anhydrous Anti-depressant Validated
1 Paroxetine HCl, Hemihydrate Anti-depressant Validated
1 Perindopril tert-butylamine Anti-hypertensive Validated
1 Pregabalin Anti-epileptic Validated
1 Quinapril Hydrochloride Anti-hypertensive Validated
1 Ramipril Anti-hypertensive Validated
1 Ranolazine Anti-angina Validated
1 Risperidone Anti-psychotic Validated
1 Rivaroxaban Anti-thrombotic Validated
1 Rocuronium Bromide Muscle Relaxants Validated
1 Ropinirole Hydrochloride Anti-parkinsonian Validated
1 Safinamide Parkinson Validated
1 Sitagliptin Anti-diabetic Validated
1 Tadalafil Erectile dysfunction Validated
1 Telmisartan Anti-hypertensive Validated
1 Temocapril Hydrochloride Anti-hypertensive Validated
1 Tolvaptan Congestive heart failure Validated
1 Torasemide Diuretic Validated
1 Valsartan Anti-hypertensive Validated
1 Vildagliptin Anti-diabetic Validated
1 Voriconazole Anti-fungal Validated
Copyright 2018 Zhejiang Huahai Pharmaceutical Co., Ltd Zhejiang ICP is No. 05005324. Designed by Mountor.